التفاصيل البيبلوغرافية
| العنوان: |
Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020. |
| المؤلفون: |
Bekker, Linda-Gail1 (AUTHOR) Linda-Gail.Bekker@hiv-research.org.za, Brown, Benjamin2 (AUTHOR), Joseph-Davey, Dvora3,4 (AUTHOR), Gill, Kathrine1 (AUTHOR), Moorhouse, Michelle5 (AUTHOR), Delany-Moretlwe, Sinead5 (AUTHOR), Myer, Landon4 (AUTHOR), Orrell, Catherine1,6 (AUTHOR), Rebe, Kevin7,8 (AUTHOR), Venter, W.D. Francois9 (AUTHOR), Wallis, Carole L.10 (AUTHOR) |
| المصدر: |
Southern African Journal of HIV Medicine. 2020, Vol. 21 Issue 1, p1-8. 8p. |
| مصطلحات موضوعية: |
*PRE-exposure prophylaxis, *HIV seroconversion, *HIV prevention, *HEPATITIS associated antigen |
| مستخلص: |
Pre-exposure prophylaxis (PrEP) with antiretroviral agents to prevent human immunodeficiency virus (HIV) acquisition is now a standard of care in many countries. Pre-exposure prophylaxis at this time is in the form of oral pills only, but topical rings and long-acting injectables are under investigation.[27] Who is pre-exposure prophylaxis for? B Step 2: Test for human immunodeficiency virus status: b Human immunodeficiency virus testing is required at initiation and at least 3 monthly whilst on pre-exposure prophylaxis to confirm HIV-negative status Follow HIV testing guidelines. B Post-exposure prophylaxis to pre-exposure prophylaxis: b Individuals who frequently require post-exposure prophylaxis (PEP) for HIV exposure may benefit from PrEP. [Extracted from the article] |
| قاعدة البيانات: |
Academic Search Index |
Full Text Finder